Are Circulating CD133 + Cells Biomarkers of Vascular Disease?
- 1 February 2005
- journal article
- editorial
- Published by Wolters Kluwer Health in Arteriosclerosis, Thrombosis, and Vascular Biology
- Vol. 25 (2), 270-271
- https://doi.org/10.1161/01.atv.0000154484.58485.24
Abstract
No abstract availableThis publication has 8 references indexed in Scilit:
- Granulocyte Colony-Stimulating Factor Mobilizes Functional Endothelial Progenitor Cells in Patients With Coronary Artery DiseaseArteriosclerosis, Thrombosis, and Vascular Biology, 2005
- Increase of Circulating Endothelial Progenitor Cells in Patients with Coronary Artery Disease After Exercise-Induced IschemiaArteriosclerosis, Thrombosis, and Vascular Biology, 2004
- Effects of intracoronary infusion of peripheral blood stem-cells mobilised with granulocyte-colony stimulating factor on left ventricular systolic function and restenosis after coronary stenting in myocardial infarction: the MAGIC cell randomised clinical trialThe Lancet, 2004
- Physical Training Increases Endothelial Progenitor Cells, Inhibits Neointima Formation, and Enhances AngiogenesisCirculation, 2004
- HMG-CoA reductase inhibitor mobilizes bone marrow–derived endothelial progenitor cellsJournal of Clinical Investigation, 2001
- Tissue Factor, the Emerging Link Between Inflammation, Thrombosis, and Vascular RemodelingCirculation Research, 2001
- Ischemia- and cytokine-induced mobilization of bone marrow-derived endothelial progenitor cells for neovascularizationNature Medicine, 1999
- Isolation of Putative Progenitor Endothelial Cells for AngiogenesisScience, 1997